Media Release
Basel, 26 August 2005
Hanspeter Kyburz to be commissioned to write the third Roche Commissions composition
Tomorrow (Saturday) morning, Roche is to commission the third Roche Commissions composition from the Swiss composer Hanspeter Kyburz. A ceremony will be held at the Roche Forum Buonas near Lucerne to initiate the third cycle of this innovative cultural project. Hanspeter Kyburz’s composition will receive its world premiere at the Culture and Convention Center (KKL) in Lucerne on 2 September 2006 during the Lucerne Festival, SOMMER, while its first performance in the United States will be given in New York’s Carnegie Hall on 5 October 2006 (date to be confirmed).
Speaking about the third composition commission, Franz B. Humer, Chairman and CEO of the Roche Group, said “I am delighted that such an important musician has accepted this third Roche Commissions award. Switzerland’s Hanspeter Kyburz has repeatedly demonstrated his interest in breaking new ground and is one of the most innovative musicians of our time. He exemplifies the striving for innovation that characterises all partners of Roche Commissions – the Lucerne Festival, the Cleveland Orchestra, the Carnergie Hall and Roche.”
Hanspeter Kyburz, born to Swiss parents in Lagos (Nigeria) in 1960, is one of the most gifted and best-known of Switzerland’s middle generation of composers. His work is performed by pre-eminent ensembles at all major festivals. With his analytical philosopher's mind and outstanding gifts as a composer he has produced a succession of exciting and sensuously gripping musical works. For Roche Commissions, Hanspeter Kyburz would like to realise a long-cherished dream of composing a work for voices and orchestra.
About Roche Commissions
Under the auspices of Roche Commissions, Roche regularly awards a composition commission to an outstanding contemporary composer. Roche selects the composer on the basis of recommendations made by the artistic directors of the Lucerne Festival, Carnegie Hall and the Cleveland Orchestra. The commissioned work is premiered by the Cleveland Orchestra under Franz Welser-Möst in the course of the Lucerne Festival, SOMMER. The following season, the same orchestra performs it for the first time in the United States at Carnegie Hall.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2004 sales by the Pharmaceuticals Division totalled 21.7 billion Swiss francs, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com. Besides its commitment to humanitarian causes, Roche has a tradition of support for cultural activities, particularly in the field of modern classical music and contemporary art. Thus on the occasion of the Group’s centenary in 1996, Roche provided full financing for the Mario Botta-designed Museum Tinguely which it presented to Basel.
All trademarks enjoy legal protection.
Further information
- Lucerne Festival
- Cleveland Orchestra
- Carnegie Hall
Hanspeter Kyburz to be commissioned to write the third Roche Commissions composition
Tomorrow (Saturday) morning, Roche is to commission the third Roche Commissions composition from the Swiss composer Hanspeter Kyburz. A ceremony will be held at the Roche Forum Buonas near Lucerne to initiate the third cycle of this innovative cultural project. Hanspeter Kyburz’s composition will receive its world premiere at the Culture and Convention Center (KKL) in Lucerne on 2 September 2006 during the Lucerne Festival, SOMMER, while its first performance in the United States will be given in New York’s Carnegie Hall on 5 October 2006 (date to be confirmed).
Speaking about the third composition commission, Franz B. Humer, Chairman and CEO of the Roche Group, said “I am delighted that such an important musician has accepted this third Roche Commissions award. Switzerland’s Hanspeter Kyburz has repeatedly demonstrated his interest in breaking new ground and is one of the most innovative musicians of our time. He exemplifies the striving for innovation that characterises all partners of Roche Commissions – the Lucerne Festival, the Cleveland Orchestra, the Carnergie Hall and Roche.”
Hanspeter Kyburz, born to Swiss parents in Lagos (Nigeria) in 1960, is one of the most gifted and best-known of Switzerland’s middle generation of composers. His work is performed by pre-eminent ensembles at all major festivals. With his analytical philosopher's mind and outstanding gifts as a composer he has produced a succession of exciting and sensuously gripping musical works. For Roche Commissions, Hanspeter Kyburz would like to realise a long-cherished dream of composing a work for voices and orchestra.
About Roche Commissions
Under the auspices of Roche Commissions, Roche regularly awards a composition commission to an outstanding contemporary composer. Roche selects the composer on the basis of recommendations made by the artistic directors of the Lucerne Festival, Carnegie Hall and the Cleveland Orchestra. The commissioned work is premiered by the Cleveland Orchestra under Franz Welser-Möst in the course of the Lucerne Festival, SOMMER. The following season, the same orchestra performs it for the first time in the United States at Carnegie Hall.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2004 sales by the Pharmaceuticals Division totalled 21.7 billion Swiss francs, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com. Besides its commitment to humanitarian causes, Roche has a tradition of support for cultural activities, particularly in the field of modern classical music and contemporary art. Thus on the occasion of the Group’s centenary in 1996, Roche provided full financing for the Mario Botta-designed Museum Tinguely which it presented to Basel.
All trademarks enjoy legal protection.
Further information
- Lucerne Festival
- Cleveland Orchestra
- Carnegie Hall